diabetes
GSK’s diabetes candidate enters phase III
February 19, 2009Research and Development GSK, diabetes
A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …
Sanofi-Aventis joins YouTube revolution
February 18, 2009Sales and Marketing Sanofi-Aventis, diabetes
Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …
Lilly launches diabetes patient education programme
September 12, 2008Medical Communications, Sales and Marketing diabetes, patients
Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …
Delayed Galvus cleared for 2008 European launch
December 19, 2007Sales and Marketing EU, diabetes
A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …
Avandia suffering less in Europe
December 10, 2007Sales and Marketing Avandia, diabetes
New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …
Dwindling sales mean job cuts at GSK
October 25, 2007Sales and Marketing Avandia, diabetes
GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …
Pfizer abandons Exubera
October 19, 2007Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Once predicted to be a blockbuster, inhaled insulin product Exubera is to be abandoned by Pfizer because of poor sales.Exubera …
FDA allows Avandia to stay but damage already done
August 3, 2007Sales and Marketing diabetes
An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …
Avandia scare casts doubt over its future for Alzheimer’s
June 13, 2007Sales and Marketing Avandia, diabetes, safety
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
Januvia launched in UK
April 25, 2007Sales and Marketing Januvia, diabetes
Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …
Diabetes UK report criticises cutbacks in NHS
March 23, 2007diabetes
In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …
New diabetes drug launched in UK
March 14, 2007Sales and Marketing Byetta, diabetes
A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …
Exubera approval limited to needle-phobic patients
January 26, 2007Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin
Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …
Byetta receives EU approval for Type II diabetes
November 28, 2006Sales and Marketing diabetes
Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …
Surprise delay for Novartis’ Galvus
November 15, 2006Sales and Marketing Galvus, diabetes
The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …
Latest content
